MLYS
Mineralys Therapeutics, Inc.
22.00$
-5.8%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +12.5% | +22.2% | +36.4% | +0.0% | +6.7% | -6.3% | -13.3% | -53.8% | +1,900.0% | – | |
| – | -7.7% | +50.4% | -99.9% | +109,196.7% | -0.2% | +16.3% | +24.9% | +28.3% | -9.5% | +23.9% | +12.3% | – | |
| – | -196.8% | – | -14.6% | -47.2% | -444.7% | – | – | -57.3% | -246.6% | – | – | – | |
| – | – | – | -100.0% | – | -100.0% | – | – | – | – | -100.0% | – | – | |
| – | -301.9% | +591.7% | – | +929.0% | +5.0% | -211.1% | -53.8% | +251.0% | -31.2% | -56.6% | +312.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -59.8% | +156,933.8% | -100.1% | -99.3% | – | +210,210.0% | -94.8% | +2,902.6% | -67.2% | -74.9% | +902.2% | – | |
| – | – | – | -154.9% | – | -42.8% | +202.8% | -224.2% | – | -138.6% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.